Camostat mesilate inhibits pro-inflammatory cytokine secretion and improves cell viability by regulating MFGE8 and HMGN1 in lipopolysaccharide-stimulated DF-1 chicken embryo fibroblasts
Camostat mesilate (CM) possesses potential anti-viral and anti-inflammatory activities. However, it remains unknown whether CM is involved in lipopolysaccharide (LPS)-mediated inflammatory responses and cell injury. In this project, differentially expressed proteins (DEPs, fold change ≥ 1.2 or ≤ 0.8...
Main Authors: | Lin Yuan, Mengjie Li, Zhishuai Zhang, Wanli Li, Wei Jin, Mingfa Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12053.pdf |
Similar Items
-
A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats
by: Yasunobu Iwata, et al.
Published: (2023-10-01) -
Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels
by: Yutaka Kakizoe, et al.
Published: (2022-12-01) -
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
by: Taku Kinoshita, et al.
Published: (2022-09-01) -
Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19
by: Yuri Kosinsky, et al.
Published: (2022-04-01) -
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics
by: Hyung Muk Choi, et al.
Published: (2021-02-01)